SPONSOR
China-Japan Friendship Hospital
Total Trials
9
Recruiting
9
Phases
Phase 1, Phase 2, Phase 4, EARLY_Phase 1
Conditions studied: Pulmonary NodulesAdvanced Solid TumorHeart FailureIron DeficiencyVenous Thromboembolic DiseasePulmonary EmbolismVenous ThromboembolismDeep Venous ThrombosisQuality ImprovementPulmonary Hypertension
China-Japan Friendship Hospital is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Pulmonary Nodules, Advanced Solid Tumor, Heart Failure, Iron Deficiency.
The trial portfolio spans Phase 1, Phase 2, Phase 4, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — China-Japan Friendship Hospital
How many clinical trials has China-Japan Friendship Hospital sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by China-Japan Friendship Hospital, of which 9 are actively recruiting participants. These trials cover conditions including Pulmonary Nodules, Advanced Solid Tumor, Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does China-Japan Friendship Hospital research focus on?
China-Japan Friendship Hospital clinical trials span Pulmonary Nodules, Advanced Solid Tumor, Heart Failure, Iron Deficiency, Venous Thromboembolic Disease, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 4, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a China-Japan Friendship Hospital clinical trial?
To participate in a China-Japan Friendship Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all China-Japan Friendship Hospital trials with current recruitment status updated daily.
Clinical Trials by China-Japan Friendship Hospital
NCT06056999
Recruiting
New Method to Differentiate Benign and Malignant Pulmonary Nodules.
Pulmonary Nodules
NCT06173219 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.
Advanced Solid Tumor
NCT06427343 Phase 4
Recruiting
The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
Heart Failure
NCT04211181
Recruiting
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
Venous Thromboembolic Disease
NCT06362382
Recruiting
Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension
Pulmonary Hypertension
NCT07077382
Recruiting
Pneumoconiosis and Dust Exposure China Cohort
Pneumoconiosis
NCT07392281 EARLY_Phase 1
Recruiting
Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina
Non-Coronary Obstructive Angina
NCT07509775
Recruiting
Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
Ankylosing Spondylitis (AS)
NCT06275230
Recruiting
Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD
Chronic Obstructive Pulmonary Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology